Skip to main content
Erschienen in: Applied Health Economics and Health Policy 2/2004

01.06.2004 | Article

EQ-5D versus SF-6D in an older, chronically ill patient group

verfasst von: Karen Gerard, Tricia Nicholson, Mark Mullee, Raj Mehta, Paul Roderick

Erschienen in: Applied Health Economics and Health Policy | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract

Choosing between preference-based instruments of health-related quality of life (HR-QOL) in particular situations is an important area for research. Even where instruments can be assumed to be measuring the same thing, they may not be interchangeable. The study presented investigates the extent to which EQ-5D and SF-6D instruments are interchangeable in an older, chronically ill patient group undergoing haemodialysis. Head-to-head comparisons were made using ‘practicality’, ‘descriptive validity’, ‘empirical validity’, mean utilities and associated distributions. Overall it was difficult to choose between instruments on the basis of descriptive or empirical validity, since both performed similarly. Important differences were, however, found relating to practicality: a significantly higher response rate in favour of EQ-5D; and lower levels of missing data to derive health states. Non-response was significantly associated with age and co-morbidity of respondents. We suggest that in patients undergoing haemodialysis, and potentially other older chronically ill patient groups, EQ-5D is the primary preference-based generic HR-QOL instrument.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Brazier J, Deverill M, Green C, et al. A review of the use of health status measures in economic evaluation. Health Technol Assess 1999; 3(9): 1–164 Brazier J, Deverill M, Green C, et al. A review of the use of health status measures in economic evaluation. Health Technol Assess 1999; 3(9): 1–164
2.
Zurück zum Zitat Brazier J, Roberts J, Tsuchiya A, et al. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004 Sep; 13(9): 873–84PubMedCrossRef Brazier J, Roberts J, Tsuchiya A, et al. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004 Sep; 13(9): 873–84PubMedCrossRef
3.
Zurück zum Zitat Longworth L, Bryan S. An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ 2003; 12(12): 1061–7PubMedCrossRef Longworth L, Bryan S. An empirical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ 2003; 12(12): 1061–7PubMedCrossRef
4.
Zurück zum Zitat O’Brien BJ, Spath M, Blackhouse G, et al. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Econ 2003; 12(11): 975–81PubMedCrossRef O’Brien BJ, Spath M, Blackhouse G, et al. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Econ 2003; 12(11): 975–81PubMedCrossRef
5.
Zurück zum Zitat Conner-Spady B, Suarez-Almazor ME. Variation in the estimation of quality-adjusted-life years by different preference-based instruments. Med Care 2003; 41(7): 791–801PubMedCrossRef Conner-Spady B, Suarez-Almazor ME. Variation in the estimation of quality-adjusted-life years by different preference-based instruments. Med Care 2003; 41(7): 791–801PubMedCrossRef
6.
Zurück zum Zitat Hawthorne G, Richardson J, Day NA. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med 2001; 33(5): 358–70PubMedCrossRef Hawthorne G, Richardson J, Day NA. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med 2001; 33(5): 358–70PubMedCrossRef
7.
Zurück zum Zitat Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33(5): 337–43PubMedCrossRef Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001; 33(5): 337–43PubMedCrossRef
8.
Zurück zum Zitat Brooks R, The EuroQol Group. EuroQol: the current state of play. Health Policy 1996; 37(1): 53–72PubMedCrossRef Brooks R, The EuroQol Group. EuroQol: the current state of play. Health Policy 1996; 37(1): 53–72PubMedCrossRef
9.
Zurück zum Zitat Brazier J, Usherwood T, Harper R, et al. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 1998; 51(11): 1115–28PubMedCrossRef Brazier J, Usherwood T, Harper R, et al. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 1998; 51(11): 1115–28PubMedCrossRef
10.
Zurück zum Zitat Ware Jr JE, Snow KK, Kosinski M, et al. SF-36 Health Survey: manual and interpretation guide. Boston (MA): The Health Institute, New England Medical Center, 1993 Ware Jr JE, Snow KK, Kosinski M, et al. SF-36 Health Survey: manual and interpretation guide. Boston (MA): The Health Institute, New England Medical Center, 1993
13.
Zurück zum Zitat Wight JP, Edwards L, Brazier J, et al. The SF36 as an outcome measure of services for end stage renal failure. Qual Health Care 1998; 7(4): 209–21PubMedCrossRef Wight JP, Edwards L, Brazier J, et al. The SF36 as an outcome measure of services for end stage renal failure. Qual Health Care 1998; 7(4): 209–21PubMedCrossRef
14.
Zurück zum Zitat Churchill DN, Torrance GW, Taylor DW, et al. Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med 1987; 10(1): 14–20PubMed Churchill DN, Torrance GW, Taylor DW, et al. Measurement of quality of life in end-stage renal disease: the time trade-off approach. Clin Invest Med 1987; 10(1): 14–20PubMed
15.
Zurück zum Zitat De Wit GA, Ramsteijn PG, De Charro FT. Economic evaluation of end stage renal disease treatment. Health Policy 1998; 44(3): 215–32PubMedCrossRef De Wit GA, Ramsteijn PG, De Charro FT. Economic evaluation of end stage renal disease treatment. Health Policy 1998; 44(3): 215–32PubMedCrossRef
16.
Zurück zum Zitat Roderick P, Nicholson T, Mehta R, et al. An evaluation of the costs and effective-ness of and quality of care of renal replacement therapy provision in renal satellite units in England and Wales. Health Technol Assess. In press Roderick P, Nicholson T, Mehta R, et al. An evaluation of the costs and effective-ness of and quality of care of renal replacement therapy provision in renal satellite units in England and Wales. Health Technol Assess. In press
17.
Zurück zum Zitat Kennedy C, Oxoby R, Donaldson C. Marginal contingent valuation: an empirical test. San Francisco (CA): International Health Economics Association (iHEA) 4th World Congress, 2003 Kennedy C, Oxoby R, Donaldson C. Marginal contingent valuation: an empirical test. San Francisco (CA): International Health Economics Association (iHEA) 4th World Congress, 2003
18.
Zurück zum Zitat Fitzpatrick R, Davey C, Buxton MJ, et al. Criteria for assessing patient based outcome measures for use in clinical trials. In: Stevens A, Abrams K, Brazier J, et al., editors. The advanced handbook of methods in evidence based healthcare. London: SAGE Publications, 2001: 181–94 Fitzpatrick R, Davey C, Buxton MJ, et al. Criteria for assessing patient based outcome measures for use in clinical trials. In: Stevens A, Abrams K, Brazier J, et al., editors. The advanced handbook of methods in evidence based healthcare. London: SAGE Publications, 2001: 181–94
19.
Zurück zum Zitat Brazier J, Deverill M. A checklist for judging preference-based measures of health related quality of life: learning from psychometrics. Health Econ 1999; 8(1): 45–51CrossRef Brazier J, Deverill M. A checklist for judging preference-based measures of health related quality of life: learning from psychometrics. Health Econ 1999; 8(1): 45–51CrossRef
20.
Zurück zum Zitat Kind P, Hardman G, Macran S. UK population norms for EQ-5D [discussion paper no. 172]. York: Centre for Health Economics, University of York, 1999 Kind P, Hardman G, Macran S. UK population norms for EQ-5D [discussion paper no. 172]. York: Centre for Health Economics, University of York, 1999
21.
Zurück zum Zitat Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002; 21(2): 271–92PubMedCrossRef Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002; 21(2): 271–92PubMedCrossRef
22.
Zurück zum Zitat Whynes D, Neilson A. Convergent validity of two measures of the quality of life. Health Econ 1993; 2: 229–35PubMedCrossRef Whynes D, Neilson A. Convergent validity of two measures of the quality of life. Health Econ 1993; 2: 229–35PubMedCrossRef
23.
Zurück zum Zitat Kind P, Gudex C. Measuring health status in the community: a comparison of methods. J Epidemiol Community Health 1994; 48: 86–91PubMedCrossRef Kind P, Gudex C. Measuring health status in the community: a comparison of methods. J Epidemiol Community Health 1994; 48: 86–91PubMedCrossRef
24.
Zurück zum Zitat Karnofsky D, Burcherval J. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod C, editor. New York: Columbia University Press, 1949 Karnofsky D, Burcherval J. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod C, editor. New York: Columbia University Press, 1949
25.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373–83PubMedCrossRef Charlson ME, Pompei P, Ales KL. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373–83PubMedCrossRef
26.
Zurück zum Zitat SPSS for Windows [11.5.0]. Chicago (IL): SPSS Inc, 2002 SPSS for Windows [11.5.0]. Chicago (IL): SPSS Inc, 2002
27.
Zurück zum Zitat Intercooled Stata 7.0 for Windows 98/95/NT [7.0]. College Station (TX): Stata Corporation, 2002 Intercooled Stata 7.0 for Windows 98/95/NT [7.0]. College Station (TX): Stata Corporation, 2002
28.
Zurück zum Zitat Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; I(8476): 307–10CrossRef Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; I(8476): 307–10CrossRef
29.
Zurück zum Zitat Altona DG. Practical statistics for medical research. London: Chapman & Hall, 1991 Altona DG. Practical statistics for medical research. London: Chapman & Hall, 1991
Metadaten
Titel
EQ-5D versus SF-6D in an older, chronically ill patient group
verfasst von
Karen Gerard
Tricia Nicholson
Mark Mullee
Raj Mehta
Paul Roderick
Publikationsdatum
01.06.2004
Verlag
Springer International Publishing
Erschienen in
Applied Health Economics and Health Policy / Ausgabe 2/2004
Print ISSN: 1175-5652
Elektronische ISSN: 1179-1896
DOI
https://doi.org/10.2165/00148365-200403020-00005

Weitere Artikel der Ausgabe 2/2004

Applied Health Economics and Health Policy 2/2004 Zur Ausgabe

Theme: Road Safety and Accident Prevention

Improving road safety and residential quality of life